Sandbox 128: Difference between revisions
No edit summary |
No edit summary |
||
Line 45: | Line 45: | ||
Allosteric site serves as a binding site for the substrate <scene name='36/365380/3zfz_1/25'>peptidoglycan</scene>. When the substrate binds to the <scene name='36/365380/3zfz_1/21'>allosteric site</scene> (Tyr105, Asn146, Asp295, Tyr297), a conformational change occurs at the active site, opening it and allowing catalytic action to occur. | Allosteric site serves as a binding site for the substrate <scene name='36/365380/3zfz_1/25'>peptidoglycan</scene>. When the substrate binds to the <scene name='36/365380/3zfz_1/21'>allosteric site</scene> (Tyr105, Asn146, Asp295, Tyr297), a conformational change occurs at the active site, opening it and allowing catalytic action to occur. | ||
The medicine, <scene name='37/372728/Ceftaroline/2'>ceftaroline</scene>, mimics the substrate at the <scene name='37/372728/3zfz_allosteric_site/ | The medicine, <scene name='37/372728/Ceftaroline/2'>ceftaroline</scene>, mimics the substrate at the <scene name='37/372728/3zfz_allosteric_site/2'>allosteric site</scene> opening the active site, allowing <scene name='36/365380/3zfz_1/22'>ceftaroline</scene> to <scene name='36/365380/3zfz_1/23'>enter and bind noncovalently</scene>. |